DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Asia Pacific Pharmaceutical Contract Manufacturing Market - By Countries and Vendors - Market Trends and Forecasts (2016 - 2021)" report to their offering.
Contract Manufacturing refers to the outsourcing of manufacturing of the products to third party vendor. These Pharmaceutical Contract Manufacturers would be given the chemical formulation of the drug from the Pharmaceutical company and then prepare/manufacture in their location. Contract Manufacturing market is growing significantly since the pharmaceutical companies are focusing more on R&D of the drugs instead of manufacturing the formulated drug to stay competitive in the market. This is driving the Pharmaceutical Contract Manufacturing Market.
Active Pharmaceutical Ingredient (API) holds the highest market share while Final dosage form is estimated to be the top growing segment during the forecasted period. The companies in the upstream industry are undergoing restructuring so as to focus more on R&D and added to this; stringent regulations on the Pharmaceutical industry are compelling the companies to outsource the manufacturing of the drugs.
Pharmaceutical companies are going for less number of vendors to take volume advantage and at the same time reduce logistics costs.
- Baxter Bio Pharma Solutions
- Haupt Pharma
- Pfizer CentreSource
Key Topics Covered:
1. Research Methodology
2. Executive Summary
3. Market Overview
4. Market Dynamics
5. Pharmaceutical Contract Manufacturing Market Segmentation, Forecasts and Trends - by Revenue
6. APAC Vendor Market Share Analysis
7. Competitive Intelligence - Company Profiles
8. Investment Analysis
9. Future of Pharmaceutical Contract Manufacturing Market
For more information about this report visit http://www.researchandmarkets.com/research/t24bh3/asia_pacific